Hyperinsulinemia and insulinresistans in sleep apnea syndrom (SAS) Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Prevalence of the sleep apnea syndrome (SAS) in acromegaly population Source: Eur Respir J 2002; 20: Suppl. 38, 576s Year: 2002
Microalbuminuria in patients with sleep apnea syndrome (SAS), before and after CPAP use Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Airway inflammation and cold airway hyperresponsiveness in bronchial asthma patients with obstructive sleep apnea hypopnea syndrome Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Psychological profile in sleep apnea (SAS) and in primary snorers (PS) Source: Eur Respir J 2002; 20: Suppl. 38, 452s Year: 2002
Impact of CPAP on automobile accidents in patients with sleep apnoea syndrome (SAS) Source: Eur Respir J 2001; 18: Suppl. 33, 16s Year: 2001
Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)? Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016
The profile of the smoker patient with sleep apnoea syndrome (SAS) in Romania Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Upper airway evaluation by drug-induced sleep endoscopy (DISE) in children with Down syndrome and obstructive sleep apnoea Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children Year: 2013
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015
Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Bronchial inflammation in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003
Treatment of obstructive sleep apnoea syndrome (OSAS) with uvulo palatal flep (UPF) Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003
Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities? Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Pharyngeal and systemic inflammation in obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
The role of the complement system in the pathomechanism of obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017